Quantum BioPharma Ltd.
(NASDAQ) QNTM
Quantum BioPharma Ltd. Financials at a Glance
Market Cap
$19.89M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.22M
EPS (TTM)
$-8.71
P/E Ratio
-0.55
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$4.41
Volume
1,155,050
Open
$5.08
Price
$4.41
Volume
1,155,050
Open
$5.08
Previous Close
$4.41
Daily Range
$4.40 - $6.21
52-Week Range
$2.07 - $38.25
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$4.41
Volume
1,155,050
Open
$5.08
Previous Close
$4.41
Daily Range
$4.40 - $6.21
52-Week Range
$2.07 - $38.25
QNTM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Quantum BioPharma Ltd.
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Zeeshan Saeed
Website
www.quantumbiopharma.comHeadquarters
Toronto, ON M5J 2H7, CA
QNTM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-284%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-1.82%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$19.89M
Shares Outstanding
4.12M
Volume
1.16M
Short Interest
0.00%
Avg. Volume
271.65K
Financials (TTM)
Gross Profit
$555.33K
Operating Income
$15.59M
EBITDA
$15.03M
Operating Cash Flow
$8.38M
Capital Expenditure
$0.00
Free Cash Flow
$8.38M
Cash & ST Invst.
$6.17M
Total Debt
$1.87M
Quantum BioPharma Ltd. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$131.36K
N/A
Gross Margin
0.00%
N/A
Market Cap
$19.89M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$3.07M
+42.7%
EBITDA
$2.26M
+57.5%
Quarterly Fundamentals
Net Cash
$4.30M
-32.6%
Accounts Receivable
$230.63K
-93.9%
Inventory
$52.04K
-55.6%
Long Term Debt
$0.00
N/A
Short Term Debt
$1.87M
+127.0%
Return on Assets
-2.35%
N/A
Return on Invested Capital
-3.01%
N/A
Free Cash Flow
$305.25K
+63.5%
Operating Cash Flow
$305.25K
+63.5%